Skip to main content
. 2012 Nov 12;15(6):485–502. doi: 10.1111/dom.12025

Figure 1.

Figure 1

Key efficacy results from observational studies of combination therapy with insulin and a GLP-1 receptor agonist. Colour coding indicates changes in (A) HbA1c (B) body weight and (C) insulin dose between baseline and endpoint. Note, not all parameters were reported for each study.